August 20, 2010 07:52 AM Eastern Daylight Time

DUBLIN--(BUSINESS WIRE)--Research and Markets (Market of Paclitaxel Injection in China - Market Research Reports - Research and Markets) has announced the addition of the "Market of Paclitaxel Injection in China" report to their offering.

Nowadays, paclitaxel injection has been widely used to cure cancers like non-small cell lung cancer, breast cancer, and ovarian cancer, etc. Besides, paclitaxel injection has...

admin

Cigarette Smoke Causes Harmful Changes in the Lungs Even at the Lowest Levels, Study Finds

ScienceDaily (Aug. 20, 2010) — Casual smokers may think that smoking a few cigarettes a week is "no big deal." But according to new research from physician-scientists at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, having an infrequent smoke, or being exposed to secondhand smoke, may be doing more harm than people may think. The findings may further support public smoking...

admin

19 Aug, 2010 14:55 CET

PITTSBURGH, Aug. 19 – Researchers at the University of Pittsburgh Cancer Institute (UPCI) and the University of Pittsburgh School of Medicine have been awarded an $800,000 federal grant to develop agents to inhibit a cellular signaling protein that plays a key role in triggering and supporting the growth of many cancers, including cancers of the head and neck.

A member of a protein class called Signal Transducers and Activators of Transcription,...

admin

Abstract:
One of the first chemotherapy drugs given to patients diagnosed with cancer — especially lung, ovarian, or breast cancer — is cisplatin, a platinum-containing compound that binds to tumor cells' DNA. Cisplatin does a good job of killing those tumor cells, but it can also seriously damage the kidneys, which receive high doses of cisplatin because they filter the blood.

Improving Cisplatin with Nanoparticles

Bethesda, MD | Posted on August 18th, 2010
...

admin

Written by Editorial Staff
August 18, 2010

Patients with metastatic non-small cell lung cancer (NSCLC) who received early palliative care lived two months longer than patients receiving standard care and reported improved mood and quality of life, according to a study in the Aug. 19 New England Journal of Medicine (NEJM).

In an ideal model, comprehensive oncologic services for patients with metastatic disease both improves quality of life and facilitates the...

admin